feed,title,long_url,short_url
Benzinga,Chemiluminescence Immunoassay Consumables to Register Significant Revenue of US$ 22 Bn by 2032 at a CAGR of over 10% | Reveals by Persistence Market Research,https://benzinga.com/pressreleases/23/01/g30463146/chemiluminescence-immunoassay-consumables-to-register-significant-revenue-of-us-22-bn-by-2032-at-a,
